
Accure Oncology Labs Private Limited
Pharmaceutical company specializing in manufacturing, research, and trading of medicines and medical disposables.
Pharmaceutical company specializing in manufacturing, research, and trading of medicines and medical disposables.
Delhi, India
+91-XXXXXXXXXX
U24232DL2008PTC176795
176795
Private Limited Indian Non-Government Company
15 Apr 2008
30 Sep 2019
31 Mar 2019
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajay Singh ![]() | Director | 23-Mar-2017 | Current |
Asit Bose ![]() | Director | 27-Jul-2016 | Current |
Accure Oncology Labs Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 81.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.84%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2017, Accure Oncology Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ajay Singh is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Accure Oncology Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Accure Oncology Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accure Oncology Labs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Accure Oncology Labs Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Accure Oncology Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi.
Ajay Vikram Singh was appointed as a Director was appointed as a Director on 23 Mar 2017 & has been associated with this company since 8 years 4 days .
Asit Chandra Bose was appointed as a Director was appointed as a Director on 27 Jul 2016 & has been associated with this company since 8 years 8 months .
Accure Oncology Labs Private Limited was registered on 15 Apr 2008 with Roc Delhi & aged 16 years 11 months as per MCA records.
Accure Oncology Labs Private Limited was incorporated on 15 Apr 2008.
The authorized share capital of Accure Oncology Labs Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Accure Oncology Labs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Accure Oncology Labs Private Limited is Flat No.1406A 14Th Floor Building No. 89 Hemkunth Chamber, Nehru Place India, New Delhi, 110019.
The corporate identification number (CIN) of Accure Oncology Labs Private Limited is U24232DL2008PTC176795 and the company number is 176795 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2017 indicates that The net worth of Accure Oncology Labs Private Limited has experienced an downturn of -14.84%.
The most recent Balance Sheet for Accure Oncology Labs Private Limited was filed with the ROC on 31 Mar 2019.
SS
BS
VC
VT